Log in to save to my catalogue

Meropenem: continuous or extended infusion?

Meropenem: continuous or extended infusion?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_edec72d1214f4110b0aba9d8a30ebdc8

Meropenem: continuous or extended infusion?

About this item

Full title

Meropenem: continuous or extended infusion?

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2020-05, Vol.24 (1), p.192-192, Article 192

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

[...]the pharmacokinetic/pharmacodynamic (PK/PD) target was a free epithelial lining fluid (ELF) concentration of 50% of time above MIC (50% fT > MIC). [...]considering a target of 50% fT > MIC, similar results were obtained with both extended infusion (EI) over 4 h and CI (i.e., MIC up to 1 and up to 2 mg/L for both modes of infusion with 1 g/8 h...

Alternative Titles

Full title

Meropenem: continuous or extended infusion?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_edec72d1214f4110b0aba9d8a30ebdc8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_edec72d1214f4110b0aba9d8a30ebdc8

Other Identifiers

ISSN

1364-8535,1466-609X

E-ISSN

1364-8535,1466-609X,1366-609X

DOI

10.1186/s13054-020-02883-w

How to access this item